BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-595@pharmaconomics
DTSTAMP:20260707T034234Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:BBIO Catalyst — infigratinib (estimated date)
DESCRIPTION:A key catalyst for infigratinib (achondroplasia) is expected ~ Dec 31\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1743881/000114036126004995/ef20065539_ex99-1.htm\n\nTrack it: https://www.pharmaconomics.com/e/595
URL:https://www.pharmaconomics.com/e/595
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:BBIO catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR